Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Optic Nerve Diseases

• The Neuroprotective Effect of PEG-GCSF in the Traumatic Optic Neuropathy
• Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND1 Mutations
• Effect of Intravenous Methylprednisolone and Intravenous Erythropoietin in Toxic Optic Neuropathies: Randomized Clinical Trial.
• Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND4 Mutations
• Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy Associated With ND4 Mutations
• Trial of Befizal® 200 mg for the Treatment of Leber Hereditary Optic Neuropathy
• Subcutaneous Injection of Erythropoietin on Visual Functions in Patients With Late Onset Optic Neuropathy
• Intravenous Infusion of Prostaglandins as Therapy in Patients With Anterior Non-arteritic Ischemic Optic Neuropathy
• NAION Treatment With Oral Prednisolone and Erythropoietin Injection
• Efficacy & Safety of RPh201 Treatment in Patients With Previous Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
• Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis
• Traumatic Optic Neuropathy Treatment Trial 2
• Efficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year
• A Single Intravitreal Injection of rAAV2-ND4 for the Treatment of Leber's Hereditary Optic Neuropathy
• Citicoline Effect on Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
• Study to Assess the Efficacy and Safety of Raxone in LHON Patients
• Post Authorisation Safety Study With Raxone in LHON Patients
• Surgery for Traumatic Optic Neuropathy
• A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for Treatment of Leber's Hereditary Optic Neuropathy
• Safety and Efficacy of Using SightSaver Visual Evoked Potential (VEP) for VEP Monitoring in Prone Spine Surgery
• Outcomes of Steroid and Oxygen Therapy Versus Placebo Therapy in Non-arteritic Anterior Ischemic Optic Neuropathy
• ENDOTHELION Study Group: Effect of Bosentan in NAION Patients
• Erythropoietin in Methanol Associated Optic Neuropathy: A Phase-2 Clinical Trial (EPO-MAON Study)
• Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
• Retrobulbar Triamcinolone Acetonide Injection in the Treatment of NA-AION
• Emergency Administration of EPI-743 to a Single Patient With Leber's Hereditary Optic Neuropathy [LHON]
• Trial of Cyclosporine in the Acute Phase of Leber Hereditary Optic Neuropathy
• Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic Neuropathy
• Safety and Efficacy Study of RPh201 Treatment of Ischemic Optic Neuropathy (ION).
• A New Medicine to Treat Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
• Traumatic Optic Neuropathy Treatment Trial (TONTT)
• Effect of EECP on Anterior Ischemic Optic Neuropathy
• Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5%
• Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON)
• NT-501 CNTF Implant for Ischemic Optic Neuropathy: Safety, Neuroprotection and Neuroenhancement
• Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
• Comparison of Intravitreal Bevacizumab and Triamcinolone With Placebo
• Safety and Efficacy Study of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy (LHON)
• Use of Bevacizumab in Trabeculectomy Surgery
• A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
• Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients
• PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
• Intravitreal Bevacizumab for Non-Arteritic Anterior Ischemic Optic Neuropathy
• A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION
• Study to Assess Efficacy,Safety and Tolerability of Idebenone in the Treatment of Leber's Hereditary Optic Neuropathy
• Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy
• A Randomized, Double-blind, Placebo-controlled Trial of Curcumin in Leber's Hereditary Optic Neuropathy (LHON)
• Effect of Levodopa-Carbidopa on Visual Function in Patients With Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy
• Neural Conduction Along the Visual Pathways After Oral Treatment With Citicoline in Patients With Optic Nerve Diseases
• Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater